cyclosporine and Infarction, Middle Cerebral Artery

cyclosporine has been researched along with Infarction, Middle Cerebral Artery in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's6 (40.00)29.6817
2010's6 (40.00)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Ago, T; Egashira, K; Fujiwara, M; Ikeda, G; Kitazono, T; Koga, JI; Matoba, T; Nakano, K; Okahara, A; Tachibana, M; Tokutome, M; Tsutsui, H1
Chai, HT; Chen, CH; Chen, KH; Chiang, JY; Chu, YC; Huang, CR; Sung, PH; Yip, HK1
Cappucci, SP; Farrer, RG; Kartje, GL; Shepherd, DJ; Tsai, SY; Wu, JY1
Ichijo, M; Ishibashi, S; Mizusawa, H; Nomura, S; Ohkubo, T; Sanjo, N; Yokota, T1
Amani, A; Dehpour, AR; Gilani, K; Mehr, SE; Nasoohi, S; Partoazar, A; Rahimi, N; Rezayat, SM1
Baud, O; Bonnin, P; Branco, S; Charriaut-Marlangue, C; Couture-Lepetit, E; De Paulis, D; Gharib, A; Leger, PL; Ovize, M; Renolleau, S1
Lei, W; Li, K; Liu, B; Mu, S; Ouyang, L; Qu, H; Zhu, Y1
Hosaka, M; Hou, N; Imai, H; Saito, N; Takeuchi, T; Torii, S; Yamaguchi, R; Yoshimoto, Y1
Isshiki, A; Matsumoto, S; Watanabe, Y; Wieloch, T1
Heuschling, P; Hodges, H; Male, DK; Modo, M; Patel, S; Rezaie, P1
Borlongan, CV; Hess, DC; Yu, G1
Dohgu, S; Egawa, T; Kataoka, Y; Nakano, Y; Shuto, H; Yamauchi, A1
Bruce, IC; Lin, L; Shen, F; Wu, L; Xia, Q; Zhang, X1
Siesjö, BK; Yoshimoto, T1
Beaudry, F; Marier, JF; Montgomery, J; Ste-Marie, L; Vachon, P1

Other Studies

15 other study(ies) available for cyclosporine and Infarction, Middle Cerebral Artery

ArticleYear
Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia-reperfusion injury.
    Scientific reports, 2020, 09-02, Volume: 10, Issue:1

    Topics: Animals; Cyclosporine; Drug Combinations; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Permeability Transition Pore; Monocytes; Nanoparticles; Neuroprotective Agents; Peptidyl-Prolyl Isomerase F; Quinolines; RAW 264.7 Cells; Receptors, CCR2

2020
Synergic effect of combined cyclosporin and melatonin protects the brain against acute ischemic reperfusion injury.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 136

    Topics: Animals; Apoptosis; Brain; Cell Line, Tumor; Cyclosporine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Melatonin; Mice; Mitochondria; Neurons; Neuroprotective Agents; Oxidative Stress; Rats; Reperfusion Injury

2021
The Subventricular Zone Response to Stroke Is Not a Therapeutic Target of Anti-Nogo-A Immunotherapy.
    Journal of neuropathology and experimental neurology, 2017, Aug-01, Volume: 76, Issue:8

    Topics: Animals; Antibodies; Bromodeoxyuridine; Cell Movement; Cyclosporine; Disease Models, Animal; Functional Laterality; In Vitro Techniques; Infarction, Middle Cerebral Artery; Infusions, Intraventricular; Lateral Ventricles; Male; Nerve Tissue Proteins; Nogo Proteins; Nogo Receptor 1; Organ Culture Techniques; Rats; Rats, Long-Evans; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; Time Factors

2017
Elevated platelet microparticle levels after acute ischemic stroke with concurrent idiopathic thrombocytopenic purpura.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:3

    Topics: Blood Platelets; Cell-Derived Microparticles; Cerebral Angiography; Cilostazol; Cyclosporine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Middle Aged; Platelet Aggregation Inhibitors; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Tetrazoles; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Up-Regulation

2014
Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat.
    Fundamental & clinical pharmacology, 2017, Volume: 31, Issue:2

    Topics: Animals; Brain Ischemia; Cyclosporine; Disease Models, Animal; Infarction, Middle Cerebral Artery; Inflammation; Liposomes; Male; Nanoparticles; Neuroprotective Agents; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Stroke; Time Factors; Tumor Necrosis Factor-alpha

2017
Evaluation of cyclosporine A in a stroke model in the immature rat brain.
    Experimental neurology, 2011, Volume: 230, Issue:1

    Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Brain; Brain Infarction; Calcium; Cell Death; Cyclosporine; Disease Models, Animal; Functional Laterality; Glial Fibrillary Acidic Protein; Immunosuppressive Agents; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Mast Cells; Microscopy, Electron, Transmission; Mitochondria; Oxygen Consumption; Rats; Rats, Wistar; Regional Blood Flow; Spectrin; Ultrasonography, Doppler

2011
Relationship between inflammatory reaction and ischemic injury of caudate-putamen in rats: inflammatory reaction and brain ischemia.
    Anatomical science international, 2011, Volume: 86, Issue:2

    Topics: Animals; Cyclosporine; Infarction, Middle Cerebral Artery; Macrophages; Male; Neostriatum; Rats; Rats, Sprague-Dawley; T-Lymphocytes

2011
Cyclophilin C-associated protein regulation of phagocytic functions via NFAT activation in macrophages.
    Brain research, 2011, Jun-23, Volume: 1397

    Topics: Adenoviridae; Animals; Binding, Competitive; Brain Ischemia; Calcineurin; Calcium; Carrier Proteins; Cell Line; Cyclophilin C; Cyclophilins; Cyclosporine; Extracellular Matrix Proteins; Immunohistochemistry; Infarction, Middle Cerebral Artery; Macrophage Activation; Macrophages; Male; Mice; Nerve Tissue Proteins; NFATC Transcription Factors; Phagocytosis; Phosphoric Monoester Hydrolases; Protein Transport; Rats; Rats, Sprague-Dawley; Subcellular Fractions; Up-Regulation

2011
Restricted clinical efficacy of cyclosporin A on rat transient middle cerebral artery occlusion.
    Life sciences, 2002, Dec-20, Volume: 72, Issue:4-5

    Topics: Animals; Arterial Occlusive Diseases; Blood-Brain Barrier; Brain; Coloring Agents; Cyclosporine; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Neuroprotective Agents; Rats; Rats, Wistar; Tetrazolium Salts

2002
Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response.
    Brain research, 2002, Dec-20, Volume: 958, Issue:1

    Topics: Animals; Biomarkers; Brain Tissue Transplantation; Cell Line, Transformed; Cyclosporine; Disease Models, Animal; Graft Rejection; Graft Survival; Immunohistochemistry; Immunosuppression Therapy; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Lymphocyte Activation; Neurons; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Stroke

2002
Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke.
    Brain research, 2004, Aug-20, Volume: 1018, Issue:1

    Topics: Animals; Brain Ischemia; Cerebral Infarction; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke; Treatment Outcome

2004
Cyclosporin A aggravates electroshock-induced convulsions in mice with a transient middle cerebral artery occlusion.
    Cellular and molecular neurobiology, 2005, Volume: 25, Issue:5

    Topics: Animals; Animals, Outbred Strains; Blood-Brain Barrier; Cyclosporine; Electroshock; Epilepsy; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Male; Mice; Risk Factors

2005
The neuroprotection conferred by activating the mitochondrial ATP-sensitive K+ channel is mediated by inhibiting the mitochondrial permeability transition pore.
    Neuroscience letters, 2006, Jul-10, Volume: 402, Issue:1-2

    Topics: Animals; Atractyloside; Brain Infarction; Cyclosporine; Diazoxide; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neuroprotective Agents; Potassium Channels; Rats; Rats, Sprague-Dawley; Reperfusion; Time Factors

2006
Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia.
    Brain research, 1999, Aug-28, Volume: 839, Issue:2

    Topics: Animals; Blood Glucose; Blood-Brain Barrier; Body Temperature; Brain Injuries; Carbon Dioxide; Carotid Arteries; Cyclosporine; Diuretics, Osmotic; Hydrogen-Ion Concentration; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Injections, Intra-Arterial; Ischemic Attack, Transient; Male; Mannitol; Osmosis; Oxygen; Rats; Rats, Wistar; Sodium Chloride; Tacrolimus; Wounds, Stab

1999
Cyclosporin A in blood and brain tissue following intra-carotid injections in normal and stroke-induced rats.
    Brain research, 2002, Jul-05, Volume: 943, Issue:1

    Topics: Animals; Brain; Carotid Artery, Common; Cyclosporine; Infarction, Middle Cerebral Artery; Injections, Intra-Arterial; Male; Rats; Rats, Sprague-Dawley; Stroke

2002